At our institution, the utilization and positivity rates of CTPA studies for the ED patients were not significantly different in the post-pandemic period compared to the pre-pandemic period. While studies spanning a larger timeframe and involving multiple institutions are needed to test the applicability of this observation to a wider patient population beyond our defined post-pandemic period, we conclude that our study provides some confidence to the ordering provider and the radiologist in embracing the end of COVID-19 public health emergency by the WHO and the United States HHS with respect to CTPA studies.
Keyphrases
- coronavirus disease
- sars cov
- emergency department
- public health
- case control
- end stage renal disease
- computed tomography
- respiratory syndrome coronavirus
- ejection fraction
- chronic kidney disease
- optical coherence tomography
- newly diagnosed
- pulmonary hypertension
- primary care
- prognostic factors
- case report
- magnetic resonance imaging
- patient reported outcomes
- pet ct
- contrast enhanced
- adverse drug
- drug induced